The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

European Journal of Haematology

Volumn 97, Issue 5, 2016, Pages 430-438

  Englund, Annika ^a   Molin, Daniel ^a   Enblad, Gunilla ^a   Karlén, Jonas ^b   Glimelius, Ingrid ^a   Ljungman, Gustaf ^a   Amini, Rose Marie ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

eosinophils; Hodgkin; macrophages; mast cells; Microenvironment; paediatric

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EOSINOPHIL; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; NEUTROPHIL COUNT; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PRIORITY JOURNAL; HODGKIN DISEASE; INFANT; LYMPHOCYTE; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SWEDEN; TUMOR MICROENVIRONMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; FEMALE; HODGKIN DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTES; MACROPHAGES; MALE; MAST CELLS; NEOPLASM STAGING; PROGNOSIS; SWEDEN; TUMOR MICROENVIRONMENT;

EID: 84961619700     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12747     Document Type: Article

References (41)

1. Ng AK, Mauch PM. Late effects of Hodgkin's disease and its treatment. Cancer J 2009;15:164–8.
2. Enblad G, Molin D, Glimelius I, Fischer M, Nilsson G. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007;21:805–23.
3. Glimelius I, Edstrom A, Amini RM, Fischer M, Nilsson G, Sundstrom C, Enblad G, Molin D. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 2006;76:278–83.
4. Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, Venge P, Nilsson K, Sundstrom C, Enblad G, Nilsson G. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 2001;114:616–23.
5. Pinto A, Aldinucci D, Gloghini A, et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 1996;88:3299–305.
6. Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000;96:1889–99.
7. Enblad G, Sundstrom C, Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993;11:187–93.
8. von Wasielewski R, Seth S, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 2000;95:1207–13.
9. Axdorph U, Porwit-MacDonald A, Grimfors G, Bjorkholm M. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease. Leuk Lymphoma 2001;42:1055–65.
10. Keresztes K, Szollosi Z, Simon Z, Tarkanyi I, Nemes Z, Illes A. Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma. Pathol Oncol Res 2007;13:237–42.
11. Barros MH, Scheliga A, De Matteo E, Minnicelli C, Soares FA, Zalcberg IR, Hassan R. Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leuk Lymphoma 2010;51:1513–22.
12. Molin D, Edstrom A, Glimelius I, Glimelius B, Nilsson G, Sundstrom C, Enblad G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 2002;119:122–4.
13. Canioni D, Deau-Fischer B, Taupin P, et al. Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. PLoS One 2009;4:e6341.
14. Andersen MD, Kamper P, Nielsen PS, Bendix K, Riber-Hansen R, Steiniche T, Hamilton-Dutoit S, Clausen M, d'Amore F. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome. Eur J Haematol 2016;96:252–9.
15. Jakovic LR, Mihaljevic BS, Perunicic Jovanovic MD, Bogdanovic AD, Andjelic BM, Bumbasirevic VZ. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma. Leuk Lymphoma 2011;52:1913–9.
16. Yoon DH, Koh YW, Kang HJ, Kim S, Park CS, Lee SW, Suh C, Huh J. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma. Eur J Haematol 2012;88:292–305.
17. Sanchez-Espiridion B, Martin-Moreno AM, Montalban C, Medeiros LJ, Vega F, Younes A, Piris MA, Garcia JF. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma. Haematologica 2012;97:1080–4.
18. Tan KL, Scott DW, Hong F, et al. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 2012;120:3280–7.
19. Deau B, Bachy E, Ribrag V, Delarue R, Rubio MT, Bosq J, Varet B, Brousse N, Hermine O, Canioni D. Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma. Leuk Lymphoma 2013;54:41–5.
20. Greaves P, Clear A, Coutinho R, Wilson A, Matthews J, Owen A, Shanyinde M, Lister TA, Calaminici M, Gribben JG. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol 2013;31:256–62.
21. Kamper P, Bendix K, Hamilton-Dutoit S, Honore B, Nyengaard JR, d'Amore F. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 2011;96:269–76.
22. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362:875–85.
23. Koh YW, Park CS, Yoon DH, Suh C, Huh J. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma. PLoS One 2014;9:e87066.
24. Panico L, Ronconi F, Lepore M, Tenneriello V, Cantore N, Dell'Angelo AC, Ferbo U, Ferrara F. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma. Leuk Lymphoma 2013;54:2418–25.
25. Tudor CS, Bruns H, Daniel C, Distel LV, Hartmann A, Gerbitz A, Buettner MJ. Macrophages and dendritic cells as actors in the immune reaction of classical hodgkin lymphoma. PLoS ONE 2014;9:e114345.
26. Tzankov A, Matter MS, Dirnhofer S. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology 2010;77:301–8.
27. Azambuja D, Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Ann Oncol 2012;23:736–42.
28. Kayal S, Mathur S, Karak AK, Kumar L, Sharma A, Bakhshi S, Raina V. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma. Leuk Lymphoma 2014;55:1031–7.
29. Barros MH, Hassan R, Niedobitek G. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact. Clin Cancer Res 2012;18:3762–71.
30. Gupta S, Yeh S, Chami R, Punnett A, Chung C. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma. Eur J Cancer 2013;49:3255–61.
31. Zameer MA, Premalata CS, Arunakumari B, Appaji L, Rama Rao C. Pediatric hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with epstein-barr virus. Pediatr Hematol Oncol 2015;32:229–38.
32. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989;320:502–6.
33. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375–82.
34. Huppmann AR, Nicolae A, Slack GW, Pittaluga S, Davies-Hill T, Ferry JA, Harris NL, Jaffe ES, Hasserjian RP. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol 2014;38:316–24.
35. Shankar A, Daw S. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents–a comprehensive review of biology, clinical course and treatment options. Br J Haematol 2012;159:288–98.
36. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630–6.
37. Englund A, Hopstadius C, Enblad G, Gustafsson G, Ljungman G. Hodgkin lymphoma–a survey of children and adolescents treated in Sweden 1985-2009. Acta Oncol 2015;54:41–8.
38. Glimelius I, Rubin J, Rostgaard K, et al. Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma - a population-based study. Eur J Haematol 2011;87:208–16.
39. Linabery AM, Erhardt EB, Fonstad RK, Ambinder RF, Bunin GR, Ross JA, Spector LG, Grufferman S. Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study. Int J Cancer 2014;135:1454–69.
40. Hjalgrim LL, Rostgaard K, Engholm G, Pukkala E, Johannesen TB, Olafsdottir E, Hjalgrim H. Aetiologic heterogeneity in pediatric Hodgkin lymphoma? Evidence from the Nordic countries, 1978-2010. Acta Oncol 2016;55:85–90.
41. Rostgaard K, Nielsen TR, Wohlfahrt J, Ullum H, Pedersen O, Erikstrup C, Nielsen LP, Hjalgrim H. Sibship structure and risk of infectious mononucleosis: a population-based cohort study. Int J Epidemiol 2014;43:1607–14.